Lv5
1340 积分 2021-07-20 加入
The landscape of small-molecule prodrugs
2天前
已完结
Considerations in the Immunogenicity Assessment Strategy for Oligonucleotide Therapeutics (ONTs)
1个月前
已完结
Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability
1个月前
已完结
Importance of ADME for Anticancer Prodrugs
2个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
3个月前
已完结
Bioanalytical Methods for Characterization of CAR‐T Cellular Kinetics: Comparison of PCR Assays and Matrices
3个月前
已完结
Clinical Translation of Targeted Protein Degraders
3个月前
已完结
Distribution Characteristics and Impacting Factors of Drug CYP Enzymes and Transporters in the Gastrointestinal Tract of Chinese Healthy Subjects
3个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
3个月前
已完结
Predicting Transporter mediated drug‐drug interactions (tDDI) via static and dynamic physiologically based pharmacokinetic (PBPK) modeling: A Comprehensive insight on where we are now and way forward
3个月前
已完结
皖公网安备34019202002308
